FA14s3.i
Curation
PascalFrancis
Racine
Curation
Checkpoint
PascalFrancis
Racine
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (PascalFrancis)

Index « FA14s3.i » - entrée « GBR »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
FRA < GBR < GEO  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 39.
[0-20] [0 - 20][0 - 39][20-38][20-40]
Ident.Authors (with country if any)Title
000004 (2006) R. N. Maini [Royaume-Uni] ; P. C. Taylor [Royaume-Uni] ; J. Szechinski [Pologne] ; K. Pavelka [République tchèque] ; J. Bröll [Autriche] ; G. Balint [Hongrie] ; P. Emery [Royaume-Uni] ; F. Raemen [Belgique] ; J. Petersen [Danemark] ; J. Smolen [Autriche] ; D. Thomson [Royaume-Uni] ; T. Kishimoto [Japon]Double-blind randomized controlled clinical trial of the interleukin-6 receptor antagonist, tocilizumab, in european patients with rheumatoid arthritis who had an incomplete response to methotrexate
000011 (2007) Sandra M. Sacre [Royaume-Uni] ; Stefan K. Drexler [Royaume-Uni] ; Evangelos Andreakos [Royaume-Uni] ; Marc Feldmann [Royaume-Uni] ; Fionula M. Brennan [Royaume-Uni] ; Brian M. J. Foxwell [Royaume-Uni]Could toll-like receptors provide a missing link in chronic inflammation in rheumatoid arthritis? Lessons from a study on human rheumatoid tissue
000012 (2007) Josef S. Smolen [Autriche] ; Daniel Aletaha [Autriche] ; Marcus Koeller [Autriche] ; Michael H. Weisman [États-Unis] ; Paul Emery [Royaume-Uni]New therapies for treatment of rheumatoid arthritis
000015 (2008) Tim Bongartz [États-Unis] ; Josef S. Smolen [Autriche] ; Andre Beaulieu [Canada] ; Andrea Rubbert-Roth [Allemagne] ; Cesar Ramos-Remus [Mexique] ; Josef Rovensky [Slovaquie] ; Emma Alecock [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Rieke Alten [Allemagne]Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study) : a double-blind, placebo-controlled, randomised trial. Commentary
000023 (2008) P. Emery [Royaume-Uni] ; E. Keystone [Canada] ; H. P. Tony [Allemagne] ; A. Cantagrel [France] ; R. Van Vollenhoven [Suède] ; A. Sanchez [Mexique] ; E. Alecock [Royaume-Uni] ; J. Lee [États-Unis] ; J. Kremer [États-Unis]IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals : results from a 24-week multicentre randomised placebo-controlled trial
000024 (2008) Mark C. Genovese [États-Unis] ; James D. Mckay [États-Unis] ; Evgeny L. Nasonov [Russie] ; Eduardo F. Mysler [Argentine] ; Nilzio A. Da Silva [Brésil] ; Emma Alecock [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Juan J. Gomez-Reino [Espagne]Interleukin-6 Receptor Inhibition With Tocilizumab Reduces Disease Activity in Rheumatoid Arthritis With Inadequate Response to Disease-Modifying Antirheumatic Drugs : The Tocilizumab in Combination With Traditional Disease-Modifying Antirheumatic Drug Therapy Study
000043 (2010) G. Jones [Australie] ; A. Sebba [États-Unis] ; J. Gu [République populaire de Chine] ; M. B. Lowenstein [États-Unis] ; A. Calvo [Pérou] ; J. J. Gomez-Reino [Espagne] ; D. A. Siri [Argentine] ; M. Tomsic [Slovénie] ; E. Alecock [Royaume-Uni] ; T. Woodworth [Royaume-Uni] ; M. C. Genovese [États-Unis]Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
000047 (2010) Patrick Garnero [France] ; Elizabeth Thompson [Royaume-Uni] ; Thasia Woodworth [Royaume-Uni] ; Josef S. Smolen [Autriche]Rapid and Sustained Improvement in Bone and Cartilage Turnover Markers With the Anti-Interleukin-6 Receptor Inhibitor Tocilizumab Plus Methotrexate in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate: Results From a Substudy of the Multicenter Double-Blind, Placebo-Controlled Trial of Tocilizumab in Inadequate Responders to Methotrexate Alone
000051 (2010) Ernest Suresh [Royaume-Uni]Recent advances in rheumatoid arthritis
000060 (2010) J. L. Nam [Royaume-Uni] ; K. L. Winthrop [États-Unis] ; R. F. Van Vollenhoven [Suède] ; K. Pavelka [République tchèque] ; G. Valesini [Italie] ; E. M. A. Hensor [Royaume-Uni] ; G. Worthy [Royaume-Uni] ; R. Landewe [Pays-Bas] ; J. S. Smolen [Autriche] ; P. Emery [Royaume-Uni] ; M. H. Buch [Royaume-Uni]Current evidence for the management of rheumatoid arthritis with biological disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of RA
000070 (2010) David L. Scott [Royaume-Uni] ; Frederick Wolfe [États-Unis] ; Tom W. J. Huizinga [Pays-Bas]Rheumatoid arthritis
000071 (2010) Kay Stubenrauch [Allemagne] ; Uwe Wessels [Allemagne] ; Herbert Birnboeck [Suisse] ; Francisco Ramirez [Royaume-Uni] ; Angelika Jahreis ; Julia Schleypen [Allemagne]Subset Analysis of Patients Experiencing Clinical Events of a Potentially Immunogenic Nature in the Pivotal Clinical Trials of Tocilizumab for Rheumatoid Arthritis: Evaluation of an Antidrug Antibody ELISA Using Clinical Adverse Event- Driven Immunogenicity Testing
000089 (2011) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Satoshi Terae [Japon] ; Hiroki Shirato [Japon]Simplified approach to MR image quantification of the rheumatoid wrist: a pilot study
000100 (2011) Laura Campbell [Royaume-Uni] ; CHEN CHEN [Royaume-Uni] ; Shweta S. Bhagat [Royaume-Uni] ; Richard A. Parker [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni]Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trials
000102 (2011) Joel M. Kremer [États-Unis] ; Ricardo Blanco [Espagne] ; Marek Brzosko [Pologne] ; Ruben Burgos-Vargas [Mexique] ; Anne-Marie Halland [Afrique du Sud] ; Emma Vernon [Royaume-Uni] ; Petra Ambs [Suisse] ; Roy Fleischmann [États-Unis]Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate: Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
000108 (2011) Tamotsu Kamishima [Japon] ; Kazuhide Tanimura [Japon] ; Masato Shimizu [Japon] ; Megumi Matsuhashi [Japon] ; Jun Fukae [Japon] ; Yujiro Kon [Royaume-Uni] ; Hiromi Hagiwara [Japon] ; Akihiro Narita [Japon] ; Yuko Aoki [Japon] ; Naoki Kosaka [Japon] ; Tatsuya Atsumi [Japon] ; Hiroki Shirato [Japon] ; Satoshi Terae [Japon]Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger
000109 (2011) Prashantha M. Vaitla [Royaume-Uni] ; Paul M. Radford [Royaume-Uni] ; Patrick J. Tighe [Royaume-Uni] ; Richard J. Powell [Royaume-Uni] ; Elizabeth M. Mcdermott [Royaume-Uni] ; Ian Todd [Royaume-Uni] ; Elizabeth Drewe [Royaume-Uni]Role of Interleukin-6 in a Patient With Tumor Necrosis Factor Receptor-Associated Periodic Syndrome: Assessment of Outcomes Following Treatment With the Anti-Interleukin-6 Receptor Monoclonal Antibody Tocilizumab
000117 (2011) Janet S. Lee [États-Unis] ; JIANMEI WANG [Royaume-Uni] ; Mitchell Martin [États-Unis] ; Soren Germer [États-Unis] ; Andrew Kenwright [Royaume-Uni] ; Ryma Benayed [États-Unis] ; Olivia Spleiss [Suisse] ; Adam Platt [Royaume-Uni] ; Robert Pilson [États-Unis] ; Andrew Hemmings [États-Unis] ; Michael E. Weinblatt [États-Unis] ; Neil Kaplowitz [États-Unis] ; Joel Krasnow [États-Unis]Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab
000138 (2011) Andreas V. Hadjinicolaou [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni] ; Shweta Bhagat [Royaume-Uni] ; Helen Parfrey [Royaume-Uni] ; Edwin R. Chilvers [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni]Non-infectious pulmonary complications of newer biological agents for rheumatic diseases-a systematic literature review
000147 (2012) Patrick D. W. Kiely [Royaume-Uni] ; Chris Deighton [Royaume-Uni] ; Josh Dixey [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni]Biologic agents for rheumatoid arthritis-negotiating the NICE technology appraisals
000163 (2012) Chetan B. Narshi [Royaume-Uni] ; Simon A. Allard [Royaume-Uni]Sustained response to tocilizumab, anti-IL-6 antibody, following anti-TNF-α failure in a patient with relapsing polychondritis complicated by aortitis

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PascalFrancis/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/FA14s3.i -k "GBR" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/FA14s3.i  \
                -Sk "GBR" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    indexItem
   |index=    FA14s3.i
   |clé=    GBR
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021